Evidence map›Paper›PMID 41516033›Full record

ArticleInternational journal of molecular sciences2025

Cellulose-Encapsulated Magnetite Nanoparticles for Spiking of Tumor Cells Positive for the Membrane-Bound Hsp70.

Anastasia Dmitrieva, Vyacheslav Ryzhov, Yaroslav Marchenko, Vladimir Deriglazov, Boris Nikolaev, Lyudmila Yakovleva, Oleg Smirnov, Vasiliy Matveev, Natalia Yudintceva, Anastasiia Spitsyna and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anastasia DmitrievaPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roshcha 1, Gatchina 188300, Russia.ORCID 0009-0007-1612-199X
Vyacheslav RyzhovPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roshcha 1, Gatchina 188300, Russia.ORCID 0000-0002-0546-1805
Yaroslav MarchenkoPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roshcha 1, Gatchina 188300, Russia.ORCID 0000-0002-7923-2175
Vladimir DeriglazovPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roshcha 1, Gatchina 188300, Russia.ORCID 0000-0002-1315-9008
Boris NikolaevJSC "Technopark of Saint-Petersburg", St. Petersburg 197022, Russia.ORCID 0000-0001-7574-5996
Lyudmila YakovlevaInstitute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg 194064, Russia.ORCID 0000-0001-6151-3617
Oleg SmirnovPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roshcha 1, Gatchina 188300, Russia.
Vasiliy MatveevPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roshcha 1, Gatchina 188300, Russia.ORCID 0000-0001-9079-3363
Natalia YudintcevaInstitute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg 194064, Russia.ORCID 0000-0002-7357-1571
Anastasiia SpitsynaPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roshcha 1, Gatchina 188300, Russia.
Elena VarfolomeevaPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roshcha 1, Gatchina 188300, Russia.ORCID 0000-0003-3287-4709
Stephanie E CombsDepartment of Radiation Oncology, Klinikum Rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany.
Andrey L KonevegaPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roshcha 1, Gatchina 188300, Russia.ORCID 0000-0003-0125-7150
Maxim ShevtsovInstitute of Cytology of the Russian Academy of Sciences (RAS), St. Petersburg 194064, Russia.ORCID 0000-0002-8539-2239

Funding

Ministry of Science and Higher Education of the Russian Federation theme No1023031500033-1-1.6.7; 1.6.4; 1.6.8Technische Universität München (TUM) 785 within the DFG funding programme Open Access Publishing. R44AR079960
6 · The paper itself

Abstract

The development of highly sensitive approaches for detecting tumor cells in biological samples remains a critical challenge in laboratory and clinical oncology. In this study, we investigated the structural and magnetic properties of iron oxide nanoparticles incorporated into cellulose microspheres of two size ranges (~100 and ~700 μm) and evaluated their potential for targeted tumor cell isolation. In the smaller microspheres, magnetite-based magnetic nanoparticles (MNPs) were synthesized in situ via co-precipitation, whereas pre-synthesized MNPs were embedded into the larger microspheres. The geometrical characteristics of the resulting magnetic cellulose microspheres (MSCMNs) were assessed by confocal microscopy. Transmission electron microscopy and X-ray diffraction analyses revealed an average magnetic core size of approximately 17 nm. Magnetic properties of the MNPs within MSCMNs were characterized using a highly sensitive nonlinear magnetic response technique, and their dynamic parameters were derived using a formalism based on the stochastic Hilbert-Landau-Lifshitz equation. To evaluate their applicability in cancer diagnostics and treatment monitoring, the MSCMNs were functionalized with a TKD peptide that selectively binds membrane-associated Hsp70 (mHsp70), yielding TKD@MSCMNs. Magnetic separation enabled the isolation of tumor cells from biological fluids. The specificity of TKD-mediated binding was confirmed using Flamma648-labeled Hsp70 and compared with control alloferone-conjugated microspheres (All@MSCMNs). The ability of TKD@MSCMNs to selectively extract mHsp70-positive tumor cells was validated using C6 glioma cells and mHsp70-negative FetMSCs controls. Following co-incubation, the extraction efficiency for C6 cells was 28 ± 14%, significantly higher than that for FetMSC (7 ± 7%,

Indexed as

CelluloseHSP70 Heat-Shock ProteinsMagnetite NanoparticlesAnimalsCell Line, TumorHumansMicrospheresCelluloseHSP70 Heat-Shock ProteinsMagnetite Nanoparticlescellulose microspheresglioma cellsheat shock proteinsmagnetite nanoparticlesmembrane-bound Hsp70TKD-functionalized ferrocellulose

Identifiers

PMID41516033
PMCPMC12785830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.